Efficacy of chloroquine followed by primaquine has been monitored in 153 patients in seven districts of Azerbaijan. Chloroquine is fully effective over the first 14 days and the combination of chloroquine and primaquine is 100% effective over 28 days.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0001-706x(03)00188-8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety and efficacy of three alternative regimens against relapsing Plasmodium vivax malaria in glucose 6-phosphate dehydrogenase deficient patients in the Brazilian Amazon (ALTPRIM).
Clin Infect Dis
January 2025
Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
Background: Daily primaquine-induced hemolysis is a common cause of complications during Plasmodium vivax malaria treatment in individuals with glucose 6-phosphate dehydrogenase deficiency (G6PDd). Alternative regimens balancing safety and efficacy are needed.
Methods: G6PDd participants with P.
Suboptimal Doses of Antimalarials Relative to Increasing Body Weight and the Risk of Recurrence in the Republic of Korea Armed Forces, 2012-2021.
J Korean Med Sci
December 2024
Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Background: We aimed to analyze the epidemiology, clinical characteristics, and outcomes of malaria caused by among military members of the Republic of Korea (ROK).
Methods: We reviewed the medical records of patients diagnosed with malaria in 16 military hospitals in the ROK between 2012-2021, excluding other types of malaria, as well as imported cases and those treated in civilian hospitals.
Results: In total, 653 patients were treated for malaria.
Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study).
Malar J
December 2024
Fundação de Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil.
Background: To eliminate malaria by 2035, Brazil must address Plasmodium vivax. Previously, first-line treatment was chloroquine plus 7-day primaquine (PQ) without glucose-6-phosphate dehydrogenase (G6PD) deficiency testing. In 2021, point-of-care quantitative G6PD testing and single-dose tafenoquine (TQ) were piloted in two municipalities.
View Article and Find Full Text PDFChloroquine-primaquine therapeutic response and safety in patients with uncomplicated Plasmodium vivax malaria in the Colombian Amazon region.
Malar J
November 2024
Malaria Group, Lab 610, Faculty of Medicine, University of Antioquia, Medellin, 050010, Colombia.
Background: In Colombia, published studies on the treatment of uncomplicated Plasmodium vivax malaria with chloroquine-primaquine are scarce. The aim of this study was to evaluate the therapeutic response to two treatment regimens at the 28-day follow-up and the occurrence of adverse events in patients with P. vivax malaria.
View Article and Find Full Text PDFCharacteristics of imported and domestic malaria cases in Gyeonggi Province, Korea.
Epidemiol Health
December 2024
Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea.
Objectives: This study explored 11 years of malaria data from mandatory reporting in Gyeonggi Province, Korea, to provide information for prevention strategies by linkage to nationwide health claims data.
Methods: Reported malaria cases in Gyeonggi Province from 2011 to 2021 were linked to medical usage data from the National Health Insurance Database. Data about hospitalization, antibiotic prescription and duration, malarial species, and sociodemographic information of the cases were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!